新型冠状病毒肺炎的临床诊断、治疗与流行病学研究

doi:10.3981/j.issn.1000-7857.2020.04.002

Abstract
Figure/Table
References (0)
Related Citation (7)

Download: PDF (725 KB) HTML^new
Export: BibTeX | EndNote (RIS)

Abstract: At present, under the firm leadership of the Party Central Committee, the whole nation is fighting against the outbreak of the new coronavirus pneumonia (NCP). This is an serious infectious disease with many new clinical and epidemiological characteristics caused by a coronavirus that has never been found in humans before. For the sake of fighting the epidemic, urgent need for emergency research exists for virus characteristics, pathogenesis, transmission, clinical diagnosis and treatment, scientific prevention and control of NCP. This paper makes a summary of the current domestic and foreign literature on novel coronavirus pneumonia for you to quickly understand this new disease,In order to provide reference for further study of the disease.

Key words： novel coronavirus pneumonia infectious diseases

Received: 09 February 2020

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Fu

Cite this article:

LI Fu. Clinical diagnosis, treatment and epidemiological study of novel coronavirus pneumonia[J]. Science & Technology Review, 2020, 38(4): 15-20.

URL:

http://www.kjdb.org/EN/10.3981/j.issn.1000-7857.2020.04.002 OR http://www.kjdb.org/EN/Y2020/V38/I4/15

[1] 国家卫生健康委员会办公厅. 新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL]. (2020-02-04)[2020-02-06]. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440/files/7260301a393845fc87fcf6dd52965ecb.pdf.
[2] Corman V M, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR[J]. Eurosurveillance, 2020, doi:10.2807/1560-7917.ES.2020. 25.3.2000045.
[3] Chan J F W, Kok K H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerging Microbes & Infections, 2020, 9(1):221-236.
[4] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. The Lancet, 2020, doi:10.1016/S0140-6736(20)30251-8.
[5] Zhang H, Kang Z, Gong H, et al. The digestive system is a potential route of 2019-nCov infection:A bioinformatics analysis based on single-cell transcriptomes[J]. bioRxiv.2020, doi:https://doi.org/10.1101/2020.01.30.927806.
[6] Holshue M L, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States[J]. New England Journal of Medicine, 2020, 382(10):929-936.
[7] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. New England Journal of Medicine, 2020, doi:10.1056/NEJMoa2001316.
[8] Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China[J]. Journal of Medical Virology, 2020, doi:10.1002/jmv.25689.
[9] Chan J F W, Yuan S, Kok K H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:A study of a family cluster[J]. The Lancet, 2020, doi:10.1016/S0140-6736(20)30154-9.
[10] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020, doi:10.1016/S0140-6736(20)30183-5.
[11] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:A descriptive study[J]. The Lancet, 2020, doi:S0140-6736(20)30211-7.
[12] 管汉雄, 熊颖, 申楠茜, 等. 武汉2019新型冠状病毒(2019GnCoV)肺炎的临床影像学特征初探[J]. 放射学实践, 2020, doi:1000-0313.2020.02.001.
[13] To K K,Tsang O T, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva[J]. Clinical Infectious Diseases. 2020, doi:10.1093/cid/ciaa149.
[14] Liu K, Fang YY, Deng Y et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province[J]. Chinese Medical Journal, 2020, doi:10.1097/CM9.0000000000000744.
[15] Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Recearch, 2020, 30(3):269-271.
[16] 中华人民共和国国家卫生和计划生育委员会. 经空气传播疾病医院感染预防与控制规范[EB/OL]. (2016-12-27)[2020-02-09]. http://www.whcdc.org/wcs/Upload/201808/5b84eeb4d8b5b.pdf.
[17] Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV)[J]. BioScience Trends, 2020, doi:10.5582/bst.2020.01020.
[18] Nkengasong J. China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response[J]. Nature Medicine, 2020(26):310-311.
[19] 国家卫生健康委员会办公厅.新型冠状病毒传播途径与预防指南[EB/OL]. (2020-01-27)[2020-02-09]. http://www.nhc.gov.cn/jkj/s3578/202001/9e73060017d744aeafff8834fc0389f4.shtml.
[20] 李太生, 曹玮, 翁利, 等. 北京协和医院关于"新型冠状病毒感染的肺炎"诊疗建议方案(V2.0)[J]. 协和医学杂志, 2020, DOI:10.3969/j.issn.1674-9081.20200022.
[21] 王新燕, 吴杰, 鲁新华, 等. 河南省新型冠状病毒(2019-nCoV)感染孕产妇管理策略建议[J]. 郑州大学学报(医学版), 2020, doi:10.13705/j.issn.1671-6825.2020.01.167.
[22] 边原, 王玥媛, 杨勇,等. 新型冠状病毒感染性肺炎抗病毒药物合理使用与药学监护[J]. 医药导报, 2020, doi:10.3870/j.issn.1004-0781.2020.03.00.
[23] 王玉光, 齐文升, 马家驹, 等. 新型冠状病毒(2019-nCoV)肺炎中医临床特征与征与辨证治疗初探[J].中医杂志, 2020, doi:10.13288/j.11-2166/r.2020.04.002.
[24] Thompson R N. Novel coronavirus outbreak in Wuhan, China, 2020:Intense surveillance is vital for preventing Sustained Transmission in New Locations[J]. Journal of Clinical Medicine. 2020, 9(2):498.
[25] Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020:A data-driven analysis in the early phase of the outbreak[J]. International Journal of Infectious Diseases, 2020(92):214-217.
[26] 魏秋华, 任哲. 2019新型冠状病毒感染的肺炎疫源地消毒措施[J].中国消毒学杂志, 2020, 37(1):59-62.
[27] 李东.新型冠状病毒的社区防控策略[J/OL].[2020-02-09]. http://kns.cnki.net/kcms/detail/42.1293.R.20200203.1403.004.html.